After the First PowerPort Bellwether Verdict: What Comes Next

A Hard Result in the First Trial

If you have an implanted port claim, you may have seen headlines reporting that a jury returned a defense verdict in the first Bard PowerPort bellwether trial — meaning the jury did not find for the plaintiff in that case. Legal news outlets have also reported that plaintiff’s counsel sought a new trial following that verdict.

That is discouraging news, and it would be dishonest to describe it any other way. But a single trial result is not the end of the litigation, and it is not a ruling about your case. Understanding exactly what that jury decided — and what it had no power to decide — is the difference between reading a headline and understanding where things actually stand.

What a Bellwether Trial Actually Is

When many similar lawsuits are consolidated for pretrial handling in federal court, the court does not try them all. Instead, a small number of representative cases are selected as bellwether trials — test cases meant to show both sides how juries respond to the evidence, the witnesses, and the theories being argued.

A few things follow from that structure:

• A bellwether verdict resolves only the individual case that was tried. It does not dismiss, decide, or devalue anyone else’s claim.
• It is not a finding that the device is safe, and a plaintiff’s verdict would not have been a finding that it is unsafe. A jury weighs one plaintiff’s medical history against one set of facts.
• Consolidation itself is a case-management step. It is not a court endorsing anyone’s injury theory.

The federal judiciary and the Judicial Panel on Multidistrict Litigation both publish general background on how multidistrict proceedings are organized.

What the First Trial Was About

Reporting on the first bellwether indicates it centered on infection allegations — that the port catheter contributed to a bloodstream infection. Courthouse News reported that a surgeon testifying in the federal trial characterized the device’s infection warnings as inadequate.

That is testimony, not a finding. The jury heard it, heard the defense response, and returned a verdict for the manufacturer. What we can say accurately is that the failure-to-warn theory on infection did not persuade this particular jury on these particular facts.

The Centers for Disease Control and Prevention publishes general clinical guidance on catheter-associated bloodstream infections, which remain a recognized risk of any long-term vascular access device regardless of manufacturer. Part of what makes these cases genuinely difficult is separating a background risk from an alleged product-specific one — and that is exactly the question juries are being asked.

The Next Trial Reportedly Shifts to Fracture

According to litigation reporting, the second bellwether was set to focus on catheter fracture claims rather than infection. Additional trials have been reported as scheduled to follow over the months after.

This matters more than it may sound. Fracture and infection are different injuries supported by different evidence:

• A fracture claim often has physical evidence — imaging showing a separated catheter fragment, a retrieval procedure, an explanted device.
• An infection claim frequently depends on inference, expert testimony, and the exclusion of other sources.

A jury that was unpersuaded on one theory tells you comparatively little about how a jury will respond to the other. Both sides know this, which is why the bellwether pool was built to test more than one injury type.

The Injuries These Lawsuits Allege

The lawsuits generally allege that the port catheter can, in some patients:

• Fracture or separate, releasing a fragment into the vascular system
• Migrate from its implanted position
• Contribute to thrombosis — clotting around or within the catheter
• Contribute to bloodstream infection or sepsis
• Cause cardiac or pulmonary complications when a fragment travels to the heart or lungs

These remain allegations being litigated. No court has made a general finding that the device causes these outcomes, and the first bellwether verdict went the other way.

If you have a port and are experiencing pain at the port site, swelling in the arm, neck or chest, fever or chills, difficulty flushing the port, or new chest pain or shortness of breath, contact your treating physician promptly. Legal questions come second; the medical evaluation comes first.

Evidence the Court Has Reportedly Limited

One procedural development worth understanding: reporting indicates the court barred juries in PowerPort trials from hearing about problems with the manufacturer’s IVC filter products.

Rulings like this are ordinary in device litigation. Courts routinely decide that evidence about a different product could unfairly prejudice a jury rather than help it evaluate the product actually at issue. But the practical effect is real — plaintiffs must prove their case on the port catheter evidence alone, without reference to the company’s history with unrelated devices.

That narrows what a jury sees, and it is part of the backdrop against which the first verdict was returned.

Regulatory Context, Stated Carefully

Some coverage of this litigation has been published under headlines referencing a “chemo port recall.” Be careful with that framing. Do not assume a recall of your specific device occurred based on a headline.

The FDA maintains public databases of device recalls, adverse event reports, and safety communications through its medical device program. If you want to know whether a specific action applies to the device you received, that is the place to check — and it is something your attorney can verify against your implant records rather than something you should have to determine yourself.

Similarly, published research on port catheter complications is indexed on PubMed, and general patient information on ports used during cancer treatment is available from the National Cancer Institute. Studies in this area typically report associations between device features and complication rates. An association reported in the medical literature is not the same as proof of causation in an individual patient, and courts treat that distinction seriously.

What This Means If You Have a Claim

A few honest points:

A defense verdict in one trial does not close your claim. Cases in a consolidated proceeding are not dismissed because one bellwether was lost.

It does affect the landscape. Trial outcomes influence how both sides evaluate cases, and a defense verdict strengthens a manufacturer’s position in that evaluation. Anyone telling you otherwise is not being straight with you.

Your injury type matters. With the next bellwether reportedly focused on fracture, the evidence developed there may be more relevant to some claims than to others.

No one can tell you what your case is worth or whether it will succeed. Any lawyer who quotes you a number at the outset of a device case — particularly after a defense verdict — is guessing.

Records that help evaluate a claim typically include:

• Implant records identifying the specific port and catheter placed
• Imaging — chest X-rays, CT scans, or fluoroscopy showing fracture, migration, or a retained fragment
• Operative reports from placement, revision, or removal
• Records of the complication itself — infection workups, blood cultures, thrombosis diagnoses, hospital admissions
• Explant records if the device or a fragment was retrieved

You do not need to have all of this. You often will not know the manufacturer or model of your own port — that information lives in hospital implant logs, and it can be requested. Not knowing it is not a reason to assume you have no claim.

Timing Deadlines Are Real

Every state sets a statute of limitations governing how long after an injury a lawsuit can be filed, and device claims can also be affected by rules about when a patient reasonably should have connected an injury to a product. These periods vary meaningfully by state, and they run whether or not trials elsewhere are going well or badly.

Waiting to see how the next bellwether turns out is understandable — but it is not a legal strategy, and it can cost someone the ability to file at all.

Take the Next Step

If you or someone you love was implanted with a Bard PowerPort or similar port catheter and experienced a fracture, device migration, blood clot, bloodstream infection, or a cardiac or pulmonary complication, you can have your situation reviewed without cost or obligation.

We will tell you plainly what we think, including when we do not believe a claim is viable. Given the first bellwether result, that candor matters more than ever.

Request a free case review to have your port catheter claim evaluated.

This article is for general information only and is not legal or medical advice. It describes allegations in pending litigation, not established facts or adjudicated findings. Past or pending trial results do not predict the outcome of any other case.